drugset / Trial / NCT00839293
Comparison of Fenofibric Acid Bioavailability From ABT-335 Capsules
RandomizedCrossoverOpen-labelTreatment
Summary
The purpose of this study is to evaluate the safety and compare the bioavailability of fenofibric acid from 2 different dosage strengths of ABT-335.
Timeline
- Start
- 2009-02
- Primary completion
- 2009-03
- Completion
- —
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | ABT-335 | Small molecule | 45 mg | — |
| Subject | ABT-335 | Small molecule | 135 mg | — |
Indications
No indication recorded.